Rock Springs Capital Management LP - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 248 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.

Quarter-by-quarter ownership
Rock Springs Capital Management LP ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2023$134,855,465
-2.4%
2,685,294
+22.8%
3.61%
+9.9%
Q2 2023$138,197,670
+51.1%
2,186,672
+7.6%
3.29%
+50.7%
Q1 2023$91,466,830
+10.4%
2,033,048
+7.5%
2.18%
+9.4%
Q4 2022$82,867,053
-18.2%
1,891,510
+23.0%
1.99%
-23.8%
Q3 2022$101,352,000
+104.9%
1,538,195
+57.1%
2.62%
+81.9%
Q2 2022$49,458,000
-18.3%
979,174
+3.3%
1.44%
-5.6%
Q1 2022$60,540,000
-34.3%
947,715
+10.2%
1.52%
-28.4%
Q4 2021$92,088,000
+5.4%
859,755
+1.2%
2.13%
+15.8%
Q3 2021$87,353,000
+22.8%
849,659
+5.0%
1.84%
+30.7%
Q2 2021$71,147,000
-2.0%
808,860
+8.3%
1.41%
-11.2%
Q1 2021$72,605,000
-23.1%
746,732
-11.3%
1.58%
-20.9%
Q4 2020$94,430,000
+6.9%
842,000
-11.6%
2.00%
-10.7%
Q3 2020$88,322,000
+17.9%
952,773
-0.8%
2.24%
+9.1%
Q2 2020$74,882,000
+73.7%
960,029
+30.3%
2.05%
+15.3%
Q1 2020$43,100,000
+40.8%
737,000
+92.9%
1.78%
+84.3%
Q4 2019$30,602,000
+24.9%
382,000
+14.5%
0.97%
-0.9%
Q3 2019$24,502,000
-15.5%
333,500
+8.5%
0.98%
-7.0%
Q2 2019$29,006,000
+31.8%
307,500
+11.8%
1.05%
+23.6%
Q1 2019$22,014,000
+91.1%
275,000
+28.7%
0.85%
+56.1%
Q4 2018$11,518,000
-26.2%
213,658
+6.8%
0.54%
-3.7%
Q3 2018$15,612,000
+23.6%
200,000
+0.5%
0.56%
+16.3%
Q2 2018$12,633,000
-12.7%
199,000
+26.1%
0.49%
-21.2%
Q1 2018$14,466,000
+30.9%
157,753
+7.7%
0.62%
+23.2%
Q4 2017$11,048,000
+83.3%
146,500
+69.4%
0.50%
+80.2%
Q3 2017$6,026,00086,5000.28%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q1 2022
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 379,090$19,037,90017.25%
DAFNA Capital Management LLC 249,521$12,530,9453.90%
Rock Springs Capital Management LP 2,685,294$134,855,4653.61%
Casdin Capital, LLC 371,378$18,650,6032.06%
Novo Holdings A/S 525,000$26,365,5001.95%
CHI Advisors LLC 92,888$4,664,8351.85%
SECTORAL ASSET MANAGEMENT INC 165,890$8,330,9961.62%
Avidity Partners Management LP 751,600$37,745,3521.52%
EMERALD ADVISERS, LLC 607,037$30,485,3931.48%
EMERALD MUTUAL FUND ADVISERS TRUST 464,321$23,318,2011.41%
View complete list of BLUEPRINT MEDICINES CORP shareholders